MoneyWorks4Me

CORONA Remedies - Quaterly Results

01 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 4224.30 millions grew by 21.90 % from Rs. 3465.40 millions.Net Profit recorded in the quarter ended June 2026 rise to 29.53% to Rs. 601.00  millions  compared to R. 464.00 millions in corresponding previous quarter.Operating profit surged to 962.80 millions from the corresponding previous quarter of 718.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4224.30 3465.40 21.90 4224.30 3465.40 21.90 14031.80 11964.20 17.28
Other Income 31.50 20.20 55.94 31.50 20.20 55.94 106.50 59.30 79.60
PBIDT 962.80 718.00 34.09 962.80 718.00 34.09 3040.90 2459.10 23.66
Interest 26.90 19.90 35.18 26.90 19.90 35.18 69.70 106.00 -34.25
PBDT 935.90 698.10 34.06 935.90 698.10 34.06 2780.20 2353.10 18.15
Depreciation 132.40 89.20 48.43 132.40 89.20 48.43 378.70 371.60 1.91
PBT 803.50 608.90 31.96 803.50 608.90 31.96 2401.50 1981.50 21.20
TAX 202.50 144.90 39.75 202.50 144.90 39.75 553.00 491.00 12.63
Deferred Tax 18.70 1.90 884.21 18.70 1.90 884.21 38.20 43.00 -11.16
PAT 601.00 464.00 29.53 601.00 464.00 29.53 1848.50 1490.50 24.02
Equity 611.60 611.60 0.00 611.60 611.60 0.00 611.60 611.60 0.00
PBIDTM(%) 22.79 20.72 10.00 22.79 20.72 10.00 21.67 20.55 5.44
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..